Projects per year
Personal profile
Education
- 2014.07-2016.05 MS., University of North Carolina at Chapel Hill, US
- 1999.09-2006.05 MD, College of Medicine, Chang Gung University
- International Exchange, Wirtschaftsuniversität Wien, Austria
Experience
- 2024.10- Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- Attending Physician, Division of Cardiology, Taipei Medical University Hospital
- Deputy Director, Department of Medial Quality, Taipei Municipal Wanfang Hospital
- Attending Physician, Division of General Medicine, Department ofInternal Medicine, Taipei Municipal Wanfang Hospital
- Cardio-Oncology Fellow, University of California, San Francisco
- 2009.08-2013.12 Resident Physician, Taipei Municipal Wanfang Hospital
Fingerprint
Dive into the research topics where Yen-Chou Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
To evaluate risks of ischemic stroke, myocardial infarction, venous thromboembolism, heart failure, and atrial fibrillation associated with vascular endothelial growth factor inhibitors in Taiwanese cancer population
Chen, Y.-C. (PI)
1/1/21 → 12/31/21
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
Associations of low-density lipoprotein cholesterol and hemoglobin A1C with cardiovascular events and mortality in breast and prostate cancer patients: Mortality & Cardiovascular Risk with LDL & HbA1C in Cancer
Chen, Y. C., Lu, J. Y., Huang, C. Y. & Shao, Y. H. J., Sept 2025, In: International Journal of Cardiology: Cardiovascular Risk and Prevention. 26, 200468.Research output: Contribution to journal › Article › peer-review
Open Access -
Cardiovascular Toxicity of Angiogenesis Inhibitors Among Patients With Cancer in Taiwan: A Nested Case-Control Study
Chen, Y. C., Huang, C. Y., Lien, L. M., Chen, J. H. & Hsieh, F. I., Jan 2 2024, In: Journal of the American Heart Association. 13, 1, e030263.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Major adverse cardiovascular events of vascular endothelial growth factor tyrosine kinase inhibitors among patients with different malignancy: A systemic review and network meta-analysis
Chen, Y. C., Chen, J. H. & Hsieh, F. I., Jan 1 2024, In: Journal of the Chinese Medical Association. 87, 1, p. 48-57 10 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Citations (Scopus) -
A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma
Chen, Y.-C., Jaffer, M., Zhou, L., Moslehi, J., Forsyth, P. A. & Fecher, L. A., May 2023, In: American Society of Clinical Oncology Educational Book. 43Research output: Contribution to journal › Article › peer-review
-
Abstract P2174: Transcriptomic Profiling Of Immune Checkpoint Inhibitor Myocarditis Reveals Novel Therapeutic Targets
Qin, J., Zhang, S., Munir, A., Chen, Y.-C., Zhang, K., Li, J., Salem, J.-E. & Moslehi, J., Aug 4 2023, In: Circulation Research. 133, 1, p. AP2174Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access
Datasets
-
Cost-utility analysis of second-line anti-diabetic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Chien, C.-L. (Contributor), Chen, Y.-C. (Contributor), Malone, D. C. (Creator), Peng, Y.-L. (Contributor) & Ko, Y. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.12871744.v1, https://tandf.figshare.com/articles/dataset/Cost-utility_analysis_of_second-line_anti-diabetic_therapy_in_patients_with_type_2_diabetes_mellitus_inadequately_controlled_on_metformin/12871744/1
Dataset